$AMRN Revenue MEANS NOTHING if there is nothing left over for shareholders. For every $1 of rev, Amarin has approx .20 in the product. Phenomenal gross margin. The problem is that they spend the remaining .80 and then some selling the product. If they can't find serious efficiencies with scale then revs are meaningless. If they can find efficiencies with scale how long and how much investment will it take? Unless and until there is clarity here then the stock price will remain depressed.